Correspondence: Triple Negative Breast Cancer - A Brief Insight Into Pathophysiology.
作者信息
Agrawal Mousmi, Chowhan Amit Kumar
机构信息
Department of Pathology and Lab Medicine, All India Institute of Medical Sciences (AIIMS), Raipur, India.
出版信息
Cancer Control. 2024 Jan-Dec;31:10732748241263642. doi: 10.1177/10732748241263642.
Abstract
摘要
相似文献
1
Correspondence: Triple Negative Breast Cancer - A Brief Insight Into Pathophysiology.
Cancer Control. 2024 Jan-Dec;31:10732748241263642. doi: 10.1177/10732748241263642.
2
Progress in triple negative breast carcinoma pathophysiology: Potential therapeutic targets.
Pathol Res Pract. 2020 Apr;216(4):152874. doi: 10.1016/j.prp.2020.152874. Epub 2020 Feb 13.
3
Triple-negative breast cancer: what is known about it?
Clin J Oncol Nurs. 2014 Feb;18(1):E6-E11. doi: 10.1188/14.CJON.E6-E11.
4
Association of Adjuvant Chemotherapy With Overall Survival Among Women With Small, Node-Negative, Triple-Negative Breast Cancer.
JAMA Netw Open. 2020 Sep 1;3(9):e2016247. doi: 10.1001/jamanetworkopen.2020.16247.
5
Triple negative breast cancer in North of Morocco: clinicopathologic and prognostic features.
BMC Womens Health. 2016 Oct 22;16(1):68. doi: 10.1186/s12905-016-0346-y.
6
The PIKfyve-ArPIKfyve-Sac3 triad in human breast cancer: Functional link between elevated Sac3 phosphatase and enhanced proliferation of triple negative cell lines.
Biochem Biophys Res Commun. 2013 Oct 18;440(2):342-7. doi: 10.1016/j.bbrc.2013.09.080. Epub 2013 Sep 23.
7
Concomitant activation of GLI1 and Notch1 contributes to racial disparity of human triple negative breast cancer progression.
Elife. 2021 Dec 10;10:e70729. doi: 10.7554/eLife.70729.
8
Triple negative breast cancer with ACTH-dependent Cushing's syndrome - case report.
Pol Przegl Chir. 2019 Feb 7;91(2):45-47. doi: 10.5604/01.3001.0012.8684.
9
Co-expression of cancer testis antigens and topoisomerase 2-alpha in triple negative breast carcinomas.
Acta Histochem. 2014 Jun;116(5):740-6. doi: 10.1016/j.acthis.2014.01.003. Epub 2014 Feb 18.
10
"An addendum to breast cancer": the triple negative experience.
Support Care Cancer. 2016 Sep;24(9):3715-21. doi: 10.1007/s00520-016-3184-4. Epub 2016 Apr 1.
本文引用的文献
1
The Characteristics of Tumor Microenvironment in Triple Negative Breast Cancer.
Cancer Manag Res. 2022 Jan 3;14:1-17. doi: 10.2147/CMAR.S316700. eCollection 2022.
2
Single-cell RNA-seq dissects the intratumoral heterogeneity of triple-negative breast cancer based on gene regulatory networks.
Mol Ther Nucleic Acids. 2021 Jan 1;23:682-690. doi: 10.1016/j.omtn.2020.12.018. eCollection 2021 Mar 5.
3
Association of Circulating Tumor DNA and Circulating Tumor Cells After Neoadjuvant Chemotherapy With Disease Recurrence in Patients With Triple-Negative Breast Cancer: Preplanned Secondary Analysis of the BRE12-158 Randomized Clinical Trial.
JAMA Oncol. 2020 Sep 1;6(9):1410-1415. doi: 10.1001/jamaoncol.2020.2295.
4
Triple Negative Breast Cancer - An Overview.
Hereditary Genet. 2013;2013(Suppl 2). doi: 10.4172/2161-1041.S2-001.
5
Triple-negative breast cancer: therapeutic options.
Lancet Oncol. 2007 Mar;8(3):235-44. doi: 10.1016/S1470-2045(07)70074-8.
Zotero 插件